Literature DB >> 23350551

Relative frequencies of inherited retinal dystrophies and optic neuropathies in Southern France: assessment of 21-year data management.

Beatrice Bocquet1, Annie Lacroux, Marie-Odile Surget, Corinne Baudoin, Virginie Marquette, Gael Manes, Maxime Hebrard, Audrey Sénéchal, Cecile Delettre, Anne-Francoise Roux, Mireille Claustres, Claire-Marie Dhaenens, Jean-Michel Rozet, Isabelle Perrault, Jean-Paul Bonnefont, Josseline Kaplan, Helene Dollfus, Patrizia Amati-Bonneau, Dominique Bonneau, Pascal Reynier, Isabelle Audo, Christina Zeitz, José Alain Sahel, Veronique Paquis-Flucklinger, Patrick Calvas, Benoit Arveiler, Suzanne Kohl, Bernd Wissinger, Catherine Blanchet, Isabelle Meunier, Christian P Hamel.   

Abstract

PURPOSE: Inherited retinal dystrophies (IRDs) and inherited optic neuropathies (IONs) are rare diseases defined by specific clinical and molecular features. The relative prevalence of these conditions was determined in Southern France.
METHODS: Patients recruited from a specialized outpatient clinic over a 21-year period underwent extensive clinical investigations and 107 genes were screened by polymerase chain reaction/sequencing.
RESULTS: There were 1957 IRD cases (1481 families) distributed in 70% of pigmentary retinopathy cases (56% non-syndromic, 14% syndromic), 20% maculopathies and 7% stationary conditions. Patients with retinitis pigmentosa were the most frequent (47%) followed by Usher syndrome (10.8%). Among non-syndromic pigmentary retinopathy patients, 84% had rod-cone dystrophy, 8% cone-rod dystrophy and 5% Leber congenital amaurosis. Macular dystrophies were encountered in 398 cases (30% had Stargardt disease and 11% had Best disease). There were 184 ION cases (127 families) distributed in 51% with dominant optic neuropathies, 33% with recessive/sporadic forms and 16% with Leber hereditary optic neuropathy. Positive molecular results were obtained in 417/609 families with IRDs (68.5%) and in 27/58 with IONs (46.5%). The sequencing of 5 genes (ABCA4, USH2A, MYO7A, RPGR and PRPH2) provided a positive molecular result in 48% of 417 families with IRDs. Except for autosomal retinitis pigmentosa, in which less than half the families had positive molecular results, about 75% of families with other forms of retinal conditions had a positive molecular diagnosis.
CONCLUSIONS: Although gene discovery considerably improved molecular diagnosis in many subgroups of IRDs and IONs, retinitis pigmentosa, accounting for almost half of IRDs, remains only partly molecularly defined.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23350551     DOI: 10.3109/09286586.2012.737890

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  23 in total

Review 1.  Genes and Mutations Causing Autosomal Dominant Retinitis Pigmentosa.

Authors:  Stephen P Daiger; Sara J Bowne; Lori S Sullivan
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-10       Impact factor: 6.915

2.  FDXR Mutations Cause Sensorial Neuropathies and Expand the Spectrum of Mitochondrial Fe-S-Synthesis Diseases.

Authors:  Antoine Paul; Anthony Drecourt; Floriane Petit; Delphine Dupin Deguine; Christelle Vasnier; Myriam Oufadem; Cécile Masson; Crystel Bonnet; Saber Masmoudi; Isabelle Mosnier; Laurence Mahieu; Didier Bouccara; Josseline Kaplan; Georges Challe; Christelle Domange; Fanny Mochel; Olivier Sterkers; Sylvie Gerber; Patrick Nitschke; Christine Bole-Feysot; Laurence Jonard; Souad Gherbi; Oriane Mercati; Ines Ben Aissa; Stanislas Lyonnet; Agnès Rötig; Agnès Delahodde; Sandrine Marlin
Journal:  Am J Hum Genet       Date:  2017-09-28       Impact factor: 11.025

3.  Homozygosity mapping in autosomal recessive retinitis pigmentosa families detects novel mutations.

Authors:  Béatrice Bocquet; Nour Al Dain Marzouka; Maxime Hebrard; Gaël Manes; Audrey Sénéchal; Isabelle Meunier; Christian P Hamel
Journal:  Mol Vis       Date:  2013-12-08       Impact factor: 2.367

4.  MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome.

Authors:  Andrea Sodi; Alessandro Mariottini; Ilaria Passerini; Vittoria Murro; Iryna Tachyla; Benedetta Bianchi; Ugo Menchini; Francesca Torricelli
Journal:  Mol Vis       Date:  2014-12-23       Impact factor: 2.367

5.  Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient.

Authors:  Nicolas Cereso; Marie O Pequignot; Lorenne Robert; Fabienne Becker; Valerie De Luca; Nicolas Nabholz; Valerie Rigau; John De Vos; Christian P Hamel; Vasiliki Kalatzis
Journal:  Mol Ther Methods Clin Dev       Date:  2014-04-02       Impact factor: 6.698

6.  Phenotypic Progression of Stargardt Disease in a Large Consanguineous Tunisian Family Harboring New ABCA4 Mutations.

Authors:  Yousra Falfoul; Imen Habibi; Ahmed Turki; Ahmed Chebil; Asma Hassairi; Daniel F Schorderet; Leila El Matri
Journal:  J Ophthalmol       Date:  2018-03-15       Impact factor: 1.909

7.  Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs.

Authors:  Heidi L Schulz; Felix Grassmann; Ulrich Kellner; Georg Spital; Klaus Rüther; Herbert Jägle; Karsten Hufendiek; Philipp Rating; Cord Huchzermeyer; Maria J Baier; Bernhard H F Weber; Heidi Stöhr
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

8.  The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy.

Authors:  Simona Torriano; Nejla Erkilic; David Baux; Nicolas Cereso; Valerie De Luca; Isabelle Meunier; Mariya Moosajee; Anne-Francoise Roux; Christian P Hamel; Vasiliki Kalatzis
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

9.  Nonsyndromic retinitis pigmentosa is highly prevalent in the Jerusalem region with a high frequency of founder mutations.

Authors:  Dror Sharon; Eyal Banin
Journal:  Mol Vis       Date:  2015-07-17       Impact factor: 2.367

10.  Probing the functional impact of sub-retinal prosthesis.

Authors:  Sébastien Roux; Frédéric Matonti; Florent Dupont; Louis Hoffart; Sylvain Takerkart; Serge Picaud; Pascale Pham; Frédéric Chavane
Journal:  Elife       Date:  2016-08-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.